# EDGAR Filing Document

**Accession Number:** 0001536196
**File Stem:** 0001213900-23-009270
**Filing Date:** 2023-2
**Character Count:** 2468
**Document Hash:** 175cca84b1cb27563381200bc78e7034
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-23-009270.hdr.sgml**: 20230313

**ACCESSION NUMBER**: 0001213900-23-009270

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230208

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Can-Fite BioPharma Ltd.
- **CENTRAL INDEX KEY:** 0001536196
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** L3
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 10 BAREKET STREET, KIRYAT MATALON
- **STREET 2:** P.O. BOX 7537
- **CITY:** PETACH TIKVA
- **STATE:** L3
- **ZIP:** 4951778
- **BUSINESS PHONE:** 972 39241114

**MAIL ADDRESS:**
- **STREET 1:** 10 BAREKET STREET, KIRYAT MATALON
- **STREET 2:** P.O. BOX 7537
- **CITY:** PETACH TIKVA
- **STATE:** L3
- **ZIP:** 4951778

Can-Fite BioPharma Ltd.

10 Bareket Street

Kiryat Matalon, P.O. Box 7537

Petach-Tikva 4951778, Israel

February 8, 2023

Securities and Exchange Commission<br> Division of Corporation Finance<br> 100 F Street, N.E.<br> Washington, D.C. 20549

---

| | |
|:---|:---|
| **Re:** | **Can-Fite BioPharma Ltd.** |
|  | **Registration Statement on Form F-1**<br> **File No. 333-269485** |

---

<u>VIA EDGAR</u>

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Can-Fite BioPharma Ltd. (the "**Company**") hereby respectfully requests that the effectiveness of the Registration Statement on Form F-1 (File No. 333-269485) of the Company (the "**Registration Statement**") be accelerated so that the Company's Registration Statement will become effective at 4:30 p.m., Eastern Time, on February 10, 2023 or as soon thereafter as may be practicable.

The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, Greenberg Traurig, P.A., by calling Gary Emmanuel at (212) 801-9337. The Company hereby authorizes Mr. Emmanuel to orally modify or withdraw this request for acceleration.

---

| | | |
|:---|:---|:---|
| Very truly yours, | Very truly yours, | Very truly yours, |
| CAN-FITE BIOPHARMA LTD. | CAN-FITE BIOPHARMA LTD. | CAN-FITE BIOPHARMA LTD. |
| By: | /s/ Pnina Fishman, Ph.D. | /s/ Pnina Fishman, Ph.D. |
|  | Name: | Pnina Fishman, Ph.D. |
|  | Title: | Chief Executive Officer |

---

cc: Gary Emmanuel (Greenberg Traurig, P.A.)